Product-specific approvals with evidence and safety shown independently.
Ozempic
A medicine used in specific products for type 2 diabetes and weight management.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
Mounjaro
A medicine used in Mounjaro for type 2 diabetes and Zepbound for specific weight-related conditions.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
Victoza
A GLP-1 medicine used in different products for diabetes or weight management.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
Trulicity
A medicine used to manage type 2 diabetes, with additional product-specific cardiovascular indications.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
Forteo
A bone-building medicine for certain people with osteoporosis and high fracture risk.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
Tymlos
A medicine for selected osteoporosis populations at high risk of fracture.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
Sandostatin
A medicine used for selected conditions involving excessive hormone release.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
Somatuline Depot
A medicine used for acromegaly and selected neuroendocrine tumors.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
Leuprorelin
A hormone-directed medicine used in products for selected reproductive and cancer-related conditions.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
Gattex
A medicine for selected people with short bowel syndrome.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
Linzess
An oral medicine for specific constipation-related conditions.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
Trulance
An oral medicine for certain chronic constipation conditions.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
Prialt
A specialist medicine used for severe chronic pain in selected patients.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
Recombinant human growth hormone
A manufactured version of human growth hormone used for specific diagnosed conditions.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
Increlex
A replacement form of IGF-1 used for a narrowly defined growth disorder.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
Egrifta
A medicine for reducing excess abdominal fat in adults with HIV-associated lipodystrophy.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
Lutathera
A targeted radiation treatment for selected receptor-positive neuroendocrine tumors.
Purpose and selected risks checked against the linked product label. This short guide is not a complete label or interaction review.
IBI362
A GLP-1/glucagon medicine with product-specific approvals in China and research in other populations.
China: adult chronic weight management and type 2 diabetes, according to the sponsor. This does not represent US FDA approval.
SS-31
SS-31 is the research name commonly associated with elamipretide, the ingredient in Forzinity.
United States: Forzinity to improve muscle strength in adults and children with Barth syndrome weighing at least 30 kg, under accelerated approval. Other mitochondrial research and RUO SS-31 vials do not inherit this approval.
Icotyde
An oral peptide treatment for the labeled plaque-psoriasis population.
United States: Icotyde for moderate-to-severe plaque psoriasis in adults and patients aged 12 or older weighing at least 40 kg who are candidates for systemic therapy or phototherapy.
Lipfendra
An oral peptide medicine for lowering LDL cholesterol in its labeled population.
United States: Lipfendra as an adjunct to diet and exercise to reduce LDL cholesterol in adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia.
Mimrylo
A hepcidin-mimicking treatment for the labeled polycythemia vera population.
United States: Mimrylo for erythrocytosis in adults with polycythemia vera.